| Dr Michael Anthony Loffredo, MD | |
|
26 Gleason St, Hyannis, MA 02601-5223 | |
| (508) 771-8967 | |
| Not Available |
| Full Name | Dr Michael Anthony Loffredo |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 20 Years |
| Location | 26 Gleason St, Hyannis, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679653430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 48731 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cape Cod Healthcare | Hyannis, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cape And Islands Plastic Surgery Pc | 1254509755 | 3 |
News Archive
Using cutting-edge imaging technology, University of California, Irvine biologists have determined that uncontrolled fluctuations (known at "noise) in the concentration of the vitamin A derivative Retinoic acid (RA) can lead to disruptions in brain organization during development.
"AIDS drugs should be given to all who need them to reduce new infections, the World Health Organization said," following a three-day meeting on the topic of using antiretroviral therapy (ART) to help prevent the spread of HIV, Bloomberg reports. "Providing more antiretroviral drugs 'will achieve a significant transmission benefit,' Teguest Guerma, interim director of the WHO's AIDS department, said … 'In the past, there has been a false dichotomy between prevention and treatment. …'That is really what has been corrected. Prevention and treatment are two faces of the same coin'" (Bennett, 11/5).
Gentel Biosciences, a leader in proteomics profiling tools and RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, jointly announce today their partnership to develop and market RayBiotech's vast collection of antibody array products covering a wide variety of cytokines and other proteins for use with Gentel's APiX chromogenic detection platform.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced it has received two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the company's ToleroMune(R) cat allergy treatment significantly reduced patients' symptoms in a recently completed, large-scale phase II clinical trial. The study also confirmed the treatment's highly favourable safety profile.
› Verified 5 days ago
| Entity Name | Cape And Islands Plastic Surgery Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013209766 PECOS PAC ID: 1254509755 Enrollment ID: O20110728000383 |
News Archive
Using cutting-edge imaging technology, University of California, Irvine biologists have determined that uncontrolled fluctuations (known at "noise) in the concentration of the vitamin A derivative Retinoic acid (RA) can lead to disruptions in brain organization during development.
"AIDS drugs should be given to all who need them to reduce new infections, the World Health Organization said," following a three-day meeting on the topic of using antiretroviral therapy (ART) to help prevent the spread of HIV, Bloomberg reports. "Providing more antiretroviral drugs 'will achieve a significant transmission benefit,' Teguest Guerma, interim director of the WHO's AIDS department, said … 'In the past, there has been a false dichotomy between prevention and treatment. …'That is really what has been corrected. Prevention and treatment are two faces of the same coin'" (Bennett, 11/5).
Gentel Biosciences, a leader in proteomics profiling tools and RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, jointly announce today their partnership to develop and market RayBiotech's vast collection of antibody array products covering a wide variety of cytokines and other proteins for use with Gentel's APiX chromogenic detection platform.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced it has received two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the company's ToleroMune(R) cat allergy treatment significantly reduced patients' symptoms in a recently completed, large-scale phase II clinical trial. The study also confirmed the treatment's highly favourable safety profile.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Anthony Loffredo, MD 26 Gleason St, Hyannis, MA 02601-5223 Ph: (508) 771-8967 | Dr Michael Anthony Loffredo, MD 26 Gleason St, Hyannis, MA 02601-5223 Ph: (508) 771-8967 |
News Archive
Using cutting-edge imaging technology, University of California, Irvine biologists have determined that uncontrolled fluctuations (known at "noise) in the concentration of the vitamin A derivative Retinoic acid (RA) can lead to disruptions in brain organization during development.
"AIDS drugs should be given to all who need them to reduce new infections, the World Health Organization said," following a three-day meeting on the topic of using antiretroviral therapy (ART) to help prevent the spread of HIV, Bloomberg reports. "Providing more antiretroviral drugs 'will achieve a significant transmission benefit,' Teguest Guerma, interim director of the WHO's AIDS department, said … 'In the past, there has been a false dichotomy between prevention and treatment. …'That is really what has been corrected. Prevention and treatment are two faces of the same coin'" (Bennett, 11/5).
Gentel Biosciences, a leader in proteomics profiling tools and RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, jointly announce today their partnership to develop and market RayBiotech's vast collection of antibody array products covering a wide variety of cytokines and other proteins for use with Gentel's APiX chromogenic detection platform.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced it has received two grants totaling more than $488,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the company's ToleroMune(R) cat allergy treatment significantly reduced patients' symptoms in a recently completed, large-scale phase II clinical trial. The study also confirmed the treatment's highly favourable safety profile.
› Verified 5 days ago
Marc Charles Fater, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 51 Main St, Hyannis, MA 02601 Phone: 508-771-0290 Fax: 508-771-8671 | |
Dr. Robert Paul Yoo, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 26 Gleason St, Hyannis, MA 02601 Phone: 508-771-8967 |